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Abstract
Multi-locus sequencing typing (MLST) is widely used to monitor the phylogeny of microbial
outbreaks. However, several strains of vancomycin-resistant Enterococcus faecium
(VREfm) with a missing MLST locus (pstS) have recently emerged in Australia, with a few
cases also reported in England. Here, we identified similarly distinct strains circulating in two
neighbouring hospitals in Scotland. Whole genome sequencing of five VREfm strains iso-
lated from these hospitals identified four pstS-null strains in both hospitals, while the fifth
was multi-locus sequence type (ST) 262, which is the first documented in the UK. All five
Scottish isolates had an insertion in the tetM gene, which is associated with increased sus-
ceptibility to tetracyclines, providing no other tetracycline-resistant gene is present. Such an
insertion, which encompasses a dfrG gene and two currently uncharacterised genes, was
additionally identified in all tested vanA-type pstS-null VREfm strains (5 English and 68 Aus-
tralian). Phylogenetic comparison with other VREfm genomes indicates that the four pstS-
null Scottish isolates sequenced in this study are more closely related to pstS-null strains
from Australia rather than the English pstS-null isolates. Given how rapidly such pstS-null
strains have expanded in Australia, the emergence of this clone in Scotland raises concerns
for a potential outbreak.
Introduction
Vancomycin-resistant Enterococcus spp. (VRE) was first identified about three decades ago
and has now become a major nosocomial pathogen. It typically infects immunocompromised
patients and can cause endocarditis, bloodstream, urinary tract, and skin and skin structure
infections [1]. VRE infections are generally more serious than those caused by vancomycin-
susceptible enterococci, and are associated with higher mortality rates [2]. Among all VRE
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species, vancomycin-resistant Enterococcus faecium (VREfm) is responsible for the majority of
hospital infections. VREfm has been recently listed as a high priority pathogen for research
and development of new antibiotics by the World Health Organisation [3]. Various measures
have been implemented to monitor the spread of VREfm infections, including multi-locus
sequence typing (MLST); this relies on characterising the allelic profile of seven “house-keep-
ing” genes, located in the E. faecium chromosome [4]. Although useful, this MLST scheme is
of limited resolution to accurately capture the clonal type of isolated E. faecium strains [5–7].
Furthermore, VREfm isolates lacking the pstS MLST-gene locus have recently emerged in both
England [7] and Australia [8].
Here, we have used whole genome sequencing to identify four VREfm isolates from two
Scottish hospitals, which lack the pstS locus, and another Scottish VREfm isolate with a MLST
profile that, to the best of our knowledge, has not been previously reported in the UK. Addi-
tionally, we provide information regarding their resistance profiles and epidemiology.
Materials and methods
VRE strains were isolated from five patients in two Scottish hospitals, between January to
October 2017. These patients developed complications following either biliary or colonic sur-
gery, and had been treated with various combinations of penicillin, amoxicillin, flucloxacillin,
Tazocin, gentamicin, metronidazole and vancomycin during their hospital stay. The VRE
strains were cultured on horse blood agar with single colonies transferred to Mueller Hinton
broth (Oxoid) liquid. These were subsequently placed on Mueller Hinton agar. Single colony
cultures of these were subsequently used for DNA isolation. Genomic DNA was extracted
using an Isolate II genomic DNA kit (Bioline), using the manufacturer’s instructions for diffi-
cult to lyse Gram-positive bacteria. DNA libraries were then prepared using the NEBNext Fast
DNA Fragmentation and Library Prep Set for Ion Torrent (New England Biolabs): briefly,
1 μg of genomic DNA was fragmented, and Ion Xpess barcode adapters (Life Technologies)
were ligated to the DNA fragments; after clean-up using Agencourt AMPure XP beads (Beck-
man Coulter), 400 bp target fragments were isolated following 18 min electrophoresis on E-gel
SizeSelect agarose gels (Life Technologies); these were subsequently amplified by PCR and, fol-
lowing another clean-up with Agencourt AMPure XP beads, the quality of the resulting DNA
libraries was assessed on a 2100 Bioanalyzer (Agilent Technologies), using high sensitivity
DNA chips (Agilent Technologies).Template positive Ion Sphere particles (ISPs) for semicon-
ductor sequencing were prepared using the Ion Touch 2 System (Life Technologies). Enriched
ISPs were loaded into ion v2 BC 316 chips (2 genomes per chip) and sequenced on an Ion
PGM system (Life Technologies). Low quality reads (quality score threshold: 0.05) were
trimmed using CLC genomics Workbench (Qiagen, version 9.5.2), and resulting reads were
assembled using SPAdes (St. Petersburg genome assembler, version 3.9). Contigs having less
than 1000 bp sequences were discarded. The remaining contigs were reordered on Mauve
(version 20150226) using the complete E. faecium Aus0004 genome [9] as reference, and
resulting genome sequences were submitted to GenBank under the accessions PJZU00000000
(VREF001), PJZT00000000 (VREF002), PJZS00000000 (VREF003), PJZR00000000 (VREF
004) and PJZQ00000000 (VREF005). Antibiotic resistant genes in VREF001-5 genomes were
predicted using the Resistance Gene Identifier tool within the comprehensive antibiotic resis-
tance database (CARD) (https://card.mcmaster.ca/analyze/rgi). This tool utilizes algorithms
for identification of perfect, strict or loose matches against resistant genes of the comprehen-
sive antibiotic resistance database, based on homology and SNP models [10]. Sequence reads
of pstS-null genomes from England and Australia were obtained from European Nucleotide
Archive, and reads were assembled using CLC genomics Workbench; contigs having less than
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200 bp were discarded. In silico MLST analysis was performed using the PubMLST website
(http://pubmlst.org/) [11]. Alignments of genomes were done using the REALPHY (Reference
sequence Alignment based Phylogeny builder) online tool (version 1.12) [12], with E. faecium
Aus0004 [9], Aus0085 [13] as references, using default options (read length: 20, seed length:
22, polymorphism threshold: 0.95) and merging of reference alignments. All input genome
sequences were assembled contigs in FASTA format and the two different reference genome
alignments were combined to produce the resulting phylogenetic tree. Minimum inhibitory
concentrations (MICs; μg/ml) for vancomycin, streptomycin, spectinomycin, tetracycline,
oxytetracycline, doxycycline, minocycline and rifampicin were calculated using the microdilu-
tion method in cation adjusted Mueller-Hinton broth media (BD Biosciences), whereas MICs
(μg/ml) for all other antibiotics were obtained using VITEK 2 (bioMerieux).
Results
The Scottish VRE strains sequenced (VREF001-5) had 2.9–3.0 Mb genomes with 37.6–37.7%
GC content (Table 1). Analysis of average nucleotide identity and Tetra Correlation Search
(TCS) against database genome sequences, using JSpeciesWS (version 3.0.12) [14], showed
that all five VRE isolates were E. faecium. VREF001, VREF002, VREF004 and VREF005 were
highly related with over 99.9% identity among aligned (>97%) sequences, whereas VREF003
displayed around 16% unique sequences compared with the other four genomes. In silico
MLST analysis of VREF001-5 genomes identified VREF003 as sequence type (ST) 262, which
has not been previously reported in the UK. The other four genomes had exact matches for six
MLST alleles (atpA-9, ddl-1, gdh-1, purK-1, gyd-12, adk-1), but no match for pstS. This MLST
profile has now been assigned as ST1424 in the E. faecium MLST database (https://pubmlst.
org/efaecium/). However, despite the missing pstS in these four genomes, all VREfm strains
sequenced in this study did have a pstS homologue within a pst operon (also referred to as
pstS2), which is thought to be the actual pstS housekeeping gene in E. faecium [7,8].
We then searched for antibiotic resistance genes with perfect or strict matches to reference
genes of the comprehensive antibiotic resistance database (CARD), but also considering loose
matches with exceptional low e-value (<10−100) and/or very high identity (>66%) to the refer-
ence gene. Analysis of the gene profiles of these five isolates identified the multi-aminoglyco-
side resistance gene aac(6')-Ii, in all five strains, and aac(6')-aph(2''), in all but VREF004. The
isolates had at least one macrolide-lincosamide-streptogramin resistance gene (ermB), a pbp5
variant (designated pbp5-R) conferring resistance to β-lactams [15], for which no reference
gene exists in CARD, and the vancomycin-teicoplanin resistance gene, vanA. With the excep-
tion of VREF003, all strains had the spectinomycin resistance gene ant(9)-Ia. Lastly, VREF003
was the only strain with a tetracycline transporter gene (tetL) (Table 2). It is notable that all iso-
lates had two loose matches for the tetracycline resistance gene tetM. By further examining the
Table 1. Features of assembled sequences of the five isolates.
Isolate ID VREF001 VREF002 VREF003 VREF004 VREF005
Accession SAMN08196781 SAMN08196782 SAMN08196783 SAMN08196784 SAMN08196785
Size (bp) 2,987,950 2,990,107 2,913,585 2,999,027 2,976,182
GC Content (%) 37.6 37.6 37.7 37.6 37.6
N50 39407 36771 32649 43809 38134
L50 23 22 28 21 22
Contigs 185 185 188 184 190
Depth of coverage 194.91 131.85 170.17 182.45 218.18
https://doi.org/10.1371/journal.pone.0218185.t001
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region where these tetM-like sequences are located, we found that the five genomes had a
Tn5801-like transposon (full-length or fragment) containing a sequence similar to Staphylo-
coccus aureus Mu50 tetM gene [16], but with a 3,229 bp insertion. The trimethoprim-resis-
tance gene dfrG and two more genes with unknown function were located within this
insertion. A similar insertion has been reported previously in some ST17 and ST18 E. faecium
strains [16] which is thought to result in defective protection against tetracyclines [17]. Lastly,
all strains had a homologue of the E. faecalis IsaA gene which confers resistance to quinupris-
tin-dalfopristin. However, the product of this gene (known as EatA), unlike the>99% identical
EatAv product found in some E. faecium strains, has a threonine at position 450, which is asso-
ciated with increased susceptibility towards quinupristin-dalfopristin [18,19].
All strains exhibited high level resistance to vancomycin; 4/5 had high level resistance to tei-
coplanin, associated with the presence of vanSA (absent from VREF005, which displayed low
level resistance) and 4/5 had high level resistance to spectinomycin (apart from VREF003
which displayed low level resistance). The strains had low level resistance to streptomycin, as
well as resistance to a variety of other drugs. The low level resistance to streptomycin and spec-
tinomycin, in the absence of any gene coding for resistance to those antibiotics, is due to
decreased uptake of these drugs by E. faecium [20]. All isolates were susceptible to linezolid,
Table 2. MIC values (μg/ml) of selected antibiotics against the five Scottish VREfm isolates. Susceptibility to a given antibiotic is indicated in bold. ND: MIC value not
determined. Resistant genes identified which correspond to strict or perfect matches against antibiotic resistance genes of the comprehensive antibiotic resistance database
(CARD) are shown. Additionally, some loose matches (underlined) to CARD reference genes, which either had> 99% identity with reference CARD gene (tetL), or had
zero e-value (rpoB2), or were the sole genes that could explain differences in antimicrobial susceptibility among the five isolates (ant(9)-Ia, marA and mtrR), are shown.
The variant of a full-length penicillin-binding protein 5 gene conferring resistance to penicillins (pbp5-R), for which no reference gene in CARD exists, was found in all
genomes. Superscripted numbers at top right of resistant genes (far-right column) correspond to the sequenced strains (last digit of isolate ID) carrying these genes.
VREF001 VREF002 VREF003 VREF004 VREF005 Resistance genes
Beta-lactams Amoxicillin > 32 > 32 > 32 > 32 > 32 pbp5-R 1–5
Co-Amoxiclav > 8 > 8 > 8 > 8 > 8 pbp5-R 1–5
Glycopeptides Vancomycin 64 512 > 512 512 128 vanA 1–5, vanHA 1–3, 5, vanRA 1–5, vanSA 1–4,
vanXA 1–5, vanYA 2–4, vanZA 3
Teicoplanin > 32 > 32 > 32 > 32 4 vanA 1–5, vanHA 1–3, 5, vanRA 1–5, vanSA 1–4,
vanXA 1–5, vanYA 2–4, vanZA 3
Fluoroquinolones Ciprofloxacin > 4 > 4 > 4 > 4 ND efmA 1–5
Aminoglycosides Gentamicin > 128 > 128 > 128 > 128 > 128 aac(6')-aph(2'') 1–3, 5
Kanamycin > 128 > 128 > 128 > 128 > 128 aac(6')-aph(2'') 1–3, 5, aph(3')-IIIa 1–2, 4–5, aac
(6')-Ii 1–5
Streptomycin 32 32 32 32 32 None
Spectinomycin 512 512 32 > 512 512 ant(9)-Ia 1–2, 4–5
Tetracyclines Tetracycline � 0.25 � 0.25 > 128 � 0.25 � 0.25 tetL 3
Oxytetracycline 1 � 0.25 > 128 0.5 � 0.25 tetL 3
Doxycycline � 0.25 � 0.25 16 � 0.25 � 0.25 tetL 3
Minocycline � 0.13 � 0.13 16 � 0.13 � 0.13 tetL 3
Tigecycline � 0.13 � 0.13 � 0.13 � 0.13 � 0.13 None
Macrolides, Lincosamides,
Streptogramins
Clarithromycin > 4 > 4 > 4 > 4 > 4 ermA 1–2, 4–5, ermB 1–5
Quinupristin-
Dalfopristin
0.5 0.5 0.5 1 0.5 None
Others Chloramphenicol 8 8 � 4 8 8 None
Linezolid 2 2 2 2 2 None
Nitrofurantoin 128 256 128 256 256 Unknown
Trimethoprim > 16 > 16 > 16 > 16 > 16 dfrG 1–5
Rifampicin 16 16 1 16 16 rpoB2 1–5, marA1-2. 4–5, mtrR1-2. 4–5
https://doi.org/10.1371/journal.pone.0218185.t002
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chloramphenicol, tigecycline and Synercid (quinupristin-dalfopristin). VREF003 was the only
isolate found to be resistant to tetracycline, doxycycline, oxytetracycline and minocycline, but
unlike the other four isolates, it was susceptible to rifampicin (Table 2). Since all five isolates
had an identical rpoB2 variant (assumed to exert some level of rifampicin-resistance), the
decreased resistance of VREF003 towards rifampicin, compared to the other four strains, may
be due to the lack of any mtrR and marA homologues in the VREF003 genome. Conversely,
loose matches of these were present in the other four isolates, and such genes have been shown
to confer resistance to multiple drugs in other bacteria, including rifampicin [21,22]. Alterna-
tively, VREF001-2 and VREF004-5 may contain an mtrR-independent mechanism of reduced
permeability for rifampicin compared with VREF003 [23]. Antibiotic susceptibility tests indi-
cated that all five isolates are classified as multi-drug resistant enterococci, according to stan-
dardised international terminology [24].
We then performed a phylogenetic comparison of VREF001-5 genomes with other known
VREfm genomes reported to have a missing pstS locus; these included: 14 (out of 66 reported)
Australian strains isolated from 9 different hospitals between 2014 and 2015 [8], 5 Australian
strains (out of 202 reported within 6 local health districts) isolated from 2 different local health
districts (LHD-1 and LHD-2) in New South Wales during 2016 [25], and all five English pstS-
null E. faecium strains isolated from a single hospital (Kathy Raven, personal communication)
in 2005 [7]. In our phylogenetic analysis we also included: five hospital-associated isolates of
different MLST sequence type each, three isolates (BM4538, UAA1025 and E2883) previously
reported to have an insertion in the tetM-locus [16] and the first complete E. faecium genome,
Aus0004 [9]. The 14 Australian pstS-null genomes were carefully selected to represent pstS-
null isolates from the 66 totally reported across Australia by Carter and co-workers [8], cover-
ing all hospitals, health jurisdictions and importantly, phylogenetically distinct clades.
This analysis indicated that Scottish pstS-null isolates are most closely related to Australian
pstS-null isolates (Fig 1A; subclade 3–1), and particularly to certain ST1424 clones isolated
from New South Wales (hospital 3 and Local Health District 1). Due to the existence of long
branches within subclade 3–1 (Fig 1A), the phylogeny of that subclade was further refined by
analysis of genomes belonging only to this subclade [12] (Fig 1B). Within this subclade, all
ST1421, ST1422 and ST1424 clones were found to be closely related, whereas the sole ST1423
clone (vanB type DMG1500761) was found to diverge the most among all Australian and Scot-
tish pstS-null strains (Fig 1A–1C). English pstS-null isolates, which are all ST1477, all cluster
together (Fig 1A; subclade 2–2) and are distinct form Australian and Scottish pstS-null strains.
Nevertheless, all pstS-null clones appear to be related to ST17 clones (Fig 1A; subclade 3–2 and
Fig 1C), which suggests that the former may have derived from ST17 strains. Most of the Aus-
tralian pstS-null genomes we analysed were ST1421 (Fig 1C), in agreement with recent data
showing that ST1421 is the most common and widespread pstS-null VRE strain in Australia,
accounting for more than 70% of cases [25,26]. Since both Australian [8] and Scottish (this
study) VREfm pstS-null strains were found in different hospitals (Fig 1C), it is likely that such
clones have spread in the community. Our phylogenetic analysis further supports an intercon-
tinental ST1424 clone spread between hospitals of New South Wales and Scotland (Fig 1). On
the other hand, all English VREfm strains with missing pstS locus [7] cluster together and are
likely to have spread within the hospital from which they were isolated. VREF003 is more phy-
logenetically related to ST18 E. faecium isolates (Fig 1A), in agreement with a previous study
showing a phylogenetic relationship between ST262 and ST18 E. faecium strains [27]. Unlike
the sole pstS-null vanB type VREfm which had an intact tetM gene sequence in its genome, all
the pstS-null vanA type VREfm strains included in our phylogenetic analysis (4/4 Scottish, 18/
18 Australian and 5/5 English) (Fig 1C) had a Tn5801-like transposon with an insertion in
their tetM locus. To identify how common this insertion is, we additionally tested the
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remaining pstS-null genomes (50 vanA-type and one van-negative) from the ones reported by
Carter et al. All these, without exception, were identified to be ST1421 and to have the same
tetM insertion within a Tn5801-like transposon. Such insertion, which has been previously
documented in the MLST-typeable Aus0004, BM4538, E2883 and UAA1025 [16] (also
included in our phylogenetic analysis), was further observed in VREF003, ERR374934 and
ERR374968. Collectively, it appears that the tetM insertion in VREfm is strongly associated
with vanA type strains missing pstS (STs: 1421, 1422, 1424 and 1477), but may also be found in
some VREfms with STs: 17, 18, 80 and 262 (Fig 1C).
Discussion
MLST analysis is inferior to whole genome sequence analysis for outbreak investigations of
VREfm [7], due to the high rate of recombination events occurring within the E. faecium chro-
mosome that cannot be captured adequately by MLST analysis [27,28]. Furthermore, the
emergence of non-typeable VREfm strains poses an extra obstacle in implementing the MLST
scheme for VREfm phylogenetic analysis. Non-typeable VREfm strains have recently emerged
and have been shown to be very rare in the UK. In a study encompassing whole genome
sequencing of nearly 500 E. faecium healthcare-associated isolates from 2001–2011 in the UK
and Ireland, there were only five cases of pstS-null VRE strains, all of which were isolated from
a single English hospital, between 2004 and 2005 [7].The emergence of such strains was even
more recent in Australia: the first two strains were isolated in 2013, but numbers increased
rapidly to a total of 89 cases, by the end of 2015 [8,29,30] and to about 300 cases, by the end of
2016 [25,30,31].
Here, we report four additional non-typeable VREfm strains isolated in 2017, which are the
first identified in Scotland. Their striking genomic similarity, combined with the fact that one
was isolated from a different hospital, indicates that, although deriving from a single strain
type, they are not necessarily hospital-acquired, but may be health-care associated, or spread
within the community. Although transmission may have occurred through the frequent trans-
fer of equipment, specimens, staff and patients between these two hospitals (located in the
same health board just 14 miles apart), evidence suggests that VRE strains are also transmitted
outside hospitals, such as in long term care facilities [6]. Additionally, VRE clones can disperse
outside health-care facilities, since strains can be carried in patients for long periods, ranging
from a few months to a few years following discharge from hospital [32,33]. For the above rea-
sons VRE infections may spread over long periods and across long distances. Indeed, our phy-
logenetic analysis is indicative of an inter-continental spread between Australia and Scotland:
the closest phylogenetic relationships were identified among Australian and Scottish ST1424
clones. Such six-locus sequence type has been identified in 28.7% (58/202) of the recently
sequenced pstS-null VREfm strains from New South Wales, Australia [25]. In addition, the
spread of such strains in New South Wales is also suggestive of inter-hospital transmission for
this VREfm clone [25]. Even within the same hospital, VRE transmission routes can be pro-
longed and complex with closely related VRE strains re-appearing in the same ward after
Fig 1. Scottish pstS-null VREfm isolates are related to vanA-type Australian pstS-null VREfm isolates. (A) Phylogenetic tree of selected E. faecium genomes,
constructed using the REALPHY (Reference sequence Alignment based Phylogeny builder) online tool, with Aus0004 and Aus0085 used as reference genomes.
pstS-null genomes are present in subclades 2–2 (English isolates) and 3–1 (Australian and Scottish isolates), (B) The phylogeny of strains clustering in subclade
3–1 (A) was further refined using REALPHY with Aus0085 and ERR374968 as references. (C) The MLST sequence type (ST) and alleles, country of origin, van
genotype, hospital and year of isolation are given for each sequenced genome. � Only the Local Health District (LHD) is known for Australian strains isolated in
New South Wales hospitals during 2016. Hospitals 3 and 9 are also in New South Wales jurisdiction, but their LHD is not known. Information is given on
whether an insertion encompassing dfrG and two uncharacterised genes was found within tetM in these genomes. N/A: not applicable (no tetM sequences
found). �� Although no such insertion was identified in Aus0085, there was a frameshift mutation within its tetM gene. pstS-null genomes of same ST are
highlighted with the same colour.
https://doi.org/10.1371/journal.pone.0218185.g001
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several months, or transmitted to patients located in different wards [34]. We also observed re-
appearance of a pstS-null strain (isolate VREF005) in the same hospital, seven months after
discharge of the last carrier patient.
With the exception of one vancomycin-susceptible and one vanB type strain, all other (69)
previously sequenced pstS-null E. faecium strains have been found to be vanA type [7,8]. Con-
sistent with these studies, the newly sequenced Scottish VREfm strains with the missing pstS
locus were also vanA type. In fact, the vast majority (84.2%) of all sequenced vanA E. faecium
2016 isolates from New South Wales, have been identified as pstS-null strains [25]. Hence,
pstS-null VREfm appears to be a very successful vanA clone. We further identified that loss of
pstS in vanA type VREfm is strongly associated with an insertion in a tetM gene (74/74 cases
tested). Such insertion was present in all ST4121, ST1422 and ST1424 strains tested, isolated
from around a dozen hospitals across Australia (New South Wales, Victoria and Australian
Capital Territory) and the UK (England and Scotland), and was only absent in the sole vanB
type pstS-null E. faecium strain identified. Although we cannot exclude the possibility that
vanA-type pstS-null members with an intact or no tetM sequence exist (the vast majority of the
recently isolated ST1421 and ST1424 stains from New South Wales were excluded in our anal-
ysis), our data strongly suggest that the Tn5801-like transposon with the tetM insertion is an
extremely common feature of vanA-type pstS-null strains. How strongly associated these two
features are (missing pstS and tetM insertion), why they were co-selected in numerous vanA
type VREs and what is the significance of this association, are issues that need to be investi-
gated further. The insertion within the tetM gene apparently leads to a mutant TetM protein
which is unable to confer resistance towards tetracyclines, as it can be inferred from relevant
susceptibility tests against tetracycline, doxycycline and minocycline, using Aus0004 [17],
VREF001-2 and VREF004-5 (this study). All sequenced isolates were resistant to trimetho-
prim, and the cause of such resistance is most likely the dfrG gene inserted into the tetM locus.
None of the isolates sequenced contained a gene for tigecycline, Synercid, or linezolid resis-
tance, and as a consequence they were susceptible to these three drugs. Since these antibiotics
are frequently used for management of multi-drug-resistant enterococcal infections [1,35],
they may still be the favourable option for combating VREfm strains with a missing pstS locus.
The emergence of pstS-null VREfm strains in Scotland raises concerns for a potential out-
break. These strains were found to be highly similar to Australian pstS-null strains, which have
very rapidly expanded to become the leading strain in Australia (2016). They are causing infec-
tions in numerous hospitals and in different health jurisdictions [8,25,26]. Furthermore, the
missing pstS locus of such strains renders the—limited in resolution—MLST analysis even less
suitable for VREfm outbreak investigations. Hence, our study, like previous ones [7,8,25],
highlights the need for whole genome sequencing approaches in monitoring VREfm
epidemiology.
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